Patents Assigned to IMBA-INSTITUTE FUR MOLEKULARE BIOTECHNOLOGIE GMBH
  • Use of Inhibitors of the Renin-Angiotensin System for the Treatment of Lung Injuries
    Publication number: 20080159962
    Abstract: The invention relates to the use of Angiotensin Converting enzyme 2 (ACE2) for the preparation of a medicament for the treatment of severe acute lung injury, especially induced by acid aspiration or sepsis, of lung oedemas and lung injuries and failures connected with infection with severe acute respiratory Syndrome (SARS) Coronavirus.
    Type: Application
    Filed: May 19, 2006
    Publication date: July 3, 2008
    Applicant: IMBA-INSTITUTE FUR MOLEKULARE BIOTECHNOLOGIE GMBH
    Inventors: Josef Penninger, Yumiko Imai, Keiji Kuba, Chengyu Jiang